This test is a Molecular Multiplex Analysis in which the following are reviewed: Protein markers (tumor markers). Analysis of circulating tumor cells (ctc). A transcriptomic profile (genetic expression) is made. Genetic profile search for point mutations, deletions / duplications and SNPs (single nucleotide polymorphisms). Epigenetic profile (methylation study). Pharmacogenetic analysis. Nutrigenetics The purpose of this…
Early detection, the prognosis of the disease and a comprehensive therapeutic guide are key to saving a patient with cancer. At Genolife we use a simple blood test that can help you and your doctor stay up to date on the changes that cause the cancer to spread, become resistant or return. When the cancer…
The prostate, as it grows, can progressively compress the urethra and, therefore, cause difficulty urinating. This happens because this compression prevents the flow of urine from the bladder to the urethra and to the outside. The possible consequences are retention of urine in the bladder or reflux of urine into the kidneys and a need…
Genolife researchers report on a new test based on methods of personalized medicine and genomic medicine for the diagnosis of prostate cancer. In Mexico, approximately 2 in 10 men develop prostate cancer and approximately 5,500 succumb to the disease each year. The diagnosis of prostate cancer can be made through the blood test for prostate-specific…
Applications of pharmacogeneticsWhat is pharmacogenetics? Pharmacogenetics studies the genes that regulate the activity, metabolism and transport of drugs, identifying the genetic polymorphisms involved in each process. The most frequent cause of therapeutic failure and adverse reactions is found in the variability of each patient’s response to drugs. The individual pharmacogenetic profile allows the use of…
Adapting the drug to your patient’s dose Know to prevent This genetic study allows to identify patients in whom a certain treatment will not be effective or may have a high risk of adverse effects. Application The study is indicated: In people with a different drug effect than expected In people with a family…
Clinical use This study helps to evaluate the possibility of reducing or increasing the response to analgesics metabolized by CYP2D6 and CYP2C19 enzymes. It can also be used as a treatment strategy guide for patients who are currently taking or are being considered for these medications. Clinical history Opioids are widely used for the management…
Test for evaluation of treatment in breast cancer Breast cancer is the second cause of death in women of reproductive age in Mexico; tamo-xifen is the drug that is commonly prescribed to patients with this type of cancer, however the results of the therapy are often not as expected. Several studies have shown that endoxifene…
Pharmacogenetics is the genetic variability in the response to drugs. Pharmacogenetics aims to develop a more effective and safe therapy, reducing costs, and therefore improving the quality of care. The predictive value of pharmacogenetic analysis prevents the possible appearance of adverse effects, and allows a more personalized dose adjustment. Medications are currently one of the…
Para empezar a monitorear mi salud en espera de mi respuesta de nutrigenética, me realicé un estudio de sangre para ver mi estado general de salud. Los resultados para mi fueron en general buenos, pero si salió un poco bajo mi hemoglobina.
